Propofol reducing the expression of MALAT1 has also been demonstrated in gastric cancer, in which Propofol decreased the expression of MALAT1 to promote the sensitivity of gastric cancer cells to cisplatin (Zhang et al. 2020). This evidence concerns the gene MALAT1 and gastric cancer.